Bronchospasm: Clinical Trials

2 trials for Bronchospasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1
Phase 21Completed 1

Follow Bronchospasm: new trials by email Literature Review of Bronchospasm trials Research Report on Bronchospasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial
Ketamine, Fentanyl - Critical Illness, Asthma
Phase 2 / Phase 3CompletedHospital Nossa Senhora da Conceicao452015-06-042024-05-21
Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction
albuterol (Armstrong Albuterol HFA), Albuterol Sulfate (Provenetil-HFA), Placebo-HFA - Asthma, Bronchospasm
Phase 3TerminatedAmphastar Pharmaceuticals, Inc.242008-02-012013-07-15

Narrower conditions

Asthma (2)  ·  Bronchial Spasm (2)  ·  Critical Illness (1)

Broader conditions

Bronchial Diseases (2)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Respiratory Hypersensitivity (2)  ·  Respiratory Tract Diseases (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Albuterol (1)  ·  Fentanyl (1)  ·  Ketamine (1)  ·  RNA aptamer SUP-A-004 (1)

Sponsors

Amphastar Pharmaceuticals, Inc. (1)  ·  Hospital Nossa Senhora da Conceicao (1)

Countries

Brazil (1)  ·  United States (1)